Linking academia and industry to bring drugs to the clinic: an interview with George Tidmarsh | Zendy

George Tidmarsh | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Linking academia and industry to bring drugs to the clinic: an interview with George Tidmarsh

Author(s) -

George Tidmarsh

Publication year - 2013

Publication title -

disease models and mechanisms

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.327

H-Index - 83

eISSN - 1754-8411

pISSN - 1754-8403

DOI - 10.1242/dmm.012997

Subject(s) - george (robot) , management , pharmaceutical industry , value (mathematics) , drug industry , medical education , medicine , sociology , library science , family medicine , engineering ethics , engineering , art , art history , pharmacology , economics , computer science , machine learning

George Tidmarsh , new Senior Editor on Disease Models & Mechanisms (DMM), is a physician with an academic science and medicine background and over two decades of industry experience at the cutting edge of biotechnology and drug development. Currently CEO of La Jolla Pharmaceutical Company Inc. as well as Consulting Associate Professor at Stanford University School of Medicine, he provides an insight into the value of industry as a conduit between academic research and patient benefit.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research